Shanghai Henlius Biotech, Inc. (HKG: 2696)
Hong Kong
· Delayed Price · Currency is HKD 23.90
0.00 (0.00%)
Dec 30, 2024, 4:08 PM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 12.85 billion as of January 3, 2025. Its market cap has increased by 54.58% in one year.
Market Cap
12.85B
Enterprise Value
16.49B
Revenue
6.06B
Ranking
n/a
PE Ratio
17.33
Stock Price
23.90
Market Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has decreased from 26.66B to 12.85B, a decrease of -51.79%. That is a compound annual growth rate of -12.91%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 152.75B |
| Hansoh Pharmaceutical Group Company | 98.98B |
| JD Health International | 84.44B |
| WuXi Biologics | 68.21B |
| Sinopharm Group | 65.07B |
| Innovent Biologics | 58.15B |
| Sino Biopharmaceutical | 56.25B |
| CSPC Pharmaceutical Group | 53.70B |